Aug. 4 at 8:30 PM
$USNA Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$1.16 down -323.08% YoY
• Reported revenue of
$223.27M down -5.33% YoY
• USANA Health Sciences updated its fiscal year 2026 outlook, now expecting consolidated net sales of
$910 million, a net loss of $(11) million, and adjusted diluted EPS of
$0.76.